Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human Adenosine A2a Receptor Antibodies:
anti-Mouse (Murine) Adenosine A2a Receptor Antibodies:
anti-Rat (Rattus) Adenosine A2a Receptor Antibodies:
Go to our pre-filtered search.
Dog (Canine) Monoclonal Adenosine A2a Receptor Primary Antibody for CyTOF, FACS - ABIN447986
Khoa, Montesinos, Reiss, Delano, Awadallah, Cronstein: Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. in Journal of immunology (Baltimore, Md. : 1950) 2001
Show all 7 references for ABIN447986
Human Polyclonal Adenosine A2a Receptor Primary Antibody for EIA, IF - ABIN950277
Buira, Dentesano, Albasanz, Moreno, Martín, Ferrer, Barrachina: DNA methylation and Yin Yang-1 repress adenosine A2A receptor levels in human brain. in Journal of neurochemistry 2010
Show all 4 references for ABIN950277
Rhesus Monkey Polyclonal Adenosine A2a Receptor Primary Antibody for ELISA, WB - ABIN185549
Rétey, Adam, Honegger, Khatami, Luhmann, Jung, Berger, Landolt: A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. in Proceedings of the National Academy of Sciences of the United States of America 2005
Show all 2 references for ABIN185549
Human Polyclonal Adenosine A2a Receptor Primary Antibody for EIA, WB - ABIN783921
van der Putten, Zuiderwijk-Sick, van Straalen, de Geus, Boven, Kondova, IJzerman, Bajramovic: Differential expression of adenosine A3 receptors controls adenosine A2A receptor-mediated inhibition of TLR responses in microglia. in Journal of immunology (Baltimore, Md. : 1950) 2009
Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.
Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet.
Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.
mRNA for adenosine A(1), A(2A), A(2B (show ADRA2B Antibodies)), and A(3) receptors was expressed in arterioles and venules. Protein for A(1), A(2A), and A(2B (show ADRA2B Antibodies)), but not A(3), was detected in both microvessel types and was further demonstrated on vascular endothelial cells
Study reveals presence of adenosine A(2A) and A(2B (show ADRA2B Antibodies)) receptors as well as a role for them in lacrimal gland secretion, and especially in synergy with purinergic and cholinergic stimulation.
Low level of ADORA1 (show ADORA1 Antibodies)/ADORA2A expression increased susceptibility of brain tumor-associated epilepsy.
No association was found between the ADORA2A rs2298383 polymorphism and panic disorder. The ADORA2A TT homozygous wild-type genotype and the ACCN2 (show ACCN2 Antibodies) TT/ADORA2A CT diplotype were more represented in controls.
gene expression of A2AR in PBMCs was significantly lower in idiopathic normal-pressure hydrocephalus patients than controls
crystal structure of the adenosine A(2A) receptor bound to an engineered G protein at 3.4 A resolution
This review will provide insight into the phenotypic changes that underline the resistance to death of liver cells preconditioned by pharmacological activation of A2aR and their implications to develop innovative strategies against liver IR damage
Data suggest that A2aR binding of antagonist (here, ZM241385) exhibits multistep drug-dissociation process, with antagonist consecutively interacting with topographically distinct regions/binding sites of A2aR.
activation of the A2AR reduced oxidative stress-induced (show SQSTM1 Antibodies) DNA damage and caspase 3 (show CASP3 Antibodies) activation in GABAergic neurons
(19)F nuclear magnetic resonance is used to quantify the conformational landscape occupied by the adenosine A2A receptor (A2AR), a prototypical class A G-protein-coupled receptor (show ADRA1A Antibodies)
ST1535 metabolites ST3932 and ST4206 are effective adenosine A2A receptor antagonists which maybe useful in treating Parkinson disease.
activation of A2A adenosine receptor (AR) with an FDA-approved agonist potently permeabilizes an in vitro primary human blood-brain barrier (hBBB (show HBB Antibodies)) to the passage of chemotherapeutic drugs and T cells.
Results indicate that neuroprotection by caffeine in the MPTP (show PTPN2 Antibodies) model of Parkinson's disease relies on the A2AR, although the specific cellular localization of these receptors remains to be determined
Diabetes resulted in an increased A2A/A2B (show ADORA2B Antibodies) receptor expression in coronary arteries which resulted in enhanced A2A/A2B (show ADORA2B Antibodies)-mediated increase in coronary flow observed in diabetic hearts.
Thsi study demonstrated thata complex involvement of A2aR in the pathogenesis of chronic neuroinflammation in mice.
In the adenosine A2A receptor knock-out mouse, pulmonary hypertension develops through activation of RhoA (show RHOA Antibodies)/ROCK signaling pathway.
A2AR deletion is sufficient to prevent memory defects, hippocampal plasticity impairments as well as Tau hyperphosphorylation, in a mouse model of Alzheimer's disease
A2AR signaling regulates both basal and LPS (show TLR4 Antibodies)-induced DUSP1 (show DUSP1 Antibodies) levels in macrophages via activating the adenylate cyclase pathway.
Plasminogen (show PLG Antibodies) activation contributes to wound repair and suggest that adenosine A2A receptor activation promotes wound closure by a mechanism that depends on tPA (show PLAT Antibodies).
These results show that the dysfunction of astrocytic A2AR, by controlling GLT (show SLC1A2 Antibodies)-I activity, triggers an astrocyte-to-neuron wave of communication resulting in disrupted glutamate (show GRIN1 Antibodies) homeostasis.
This study showed that the recruitment of intracellular A2AR signaling in the hippocampus is sufficient to trigger memory dysfunction.
A novel mutual suppression feedback loop between A2AR signaling and miR (show MLXIP Antibodies)-214 in inflammation.
Adenosine A2A receptor immunoreactivity is localized at the highest levels of the striatum and external globus pallidus.
Activation of adenosine A(2A) receptors inhibited ROS (show ROS1 Antibodies) production by LPS (show IRF6 Antibodies)-stimulated equine neutrophils in a cAMP-dependent manner.
This gene encodes a protein which is one of several receptor subtypes for adenosine. The activity of the encoded protein, a G-protein coupled receptor family member, is mediated by G proteins which activate adenylyl cyclase. The encoded protein is abundant in basal ganglia, vasculature and platelets and it is a major target of caffeine.
adenosine A2a receptor
, adenosine receptor A2a
, adenosine receptor A2a.1
, A2a adenosine receptor
, adenosine receptor A2a-like
, adenosine receptor subtype A2a
, A2a, Rs
, Adenosine A2a-receptor